Home Cart Sign in  
Chemical Structure| 1945950-21-9 Chemical Structure| 1945950-21-9

Structure of PDD 00017273
CAS No.: 1945950-21-9

Chemical Structure| 1945950-21-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PDD00017273 is a potent and selective inhibitor of Poly(ADP-ribose) glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM. It catalyses hydrolysis of the O-glycosidic linkages of ADP-ribose polymers, reversing the effects of poly(ADP-ribose) polymerases (PARPs). PDD 00017273 suppresses the ZR-75-1 cells carring BRCA1 and BRCA2 wild type, and exhibits less potent activities against MDA-MB-436 cells carry the 5396 + 1G>A mutation in BRCA1. It is used for specific killing of cells defective in certain homologous recombination (HR) proteins such as breast cancer gene 1/2 (BRCA1/2).

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Chen, Zirui ; Huang, Yihua ; Yuan, Zhirong ; Xu, Kaibiao ; Guan, Yuqing ; Wang, Luqin , et al.

Abstract: Ataxia with oculomotor apraxia type 1 (AOA1) is a rare, autosomal recessive, early-onset, progressive cerebellar ataxia caused by mutations in the APTX gene, which encodes aprataxin, a DNA-adenylate hydrolase involved in DNA damage repair. The pathogenesis of AOA1 remains unclear. The purpose of this study was to investigate the pathogenesis of a novel mutation, p.H201P/H201R, carried by our AOA1 patient and the mechanism of AOA1 in an induced pluripotent stem cells (iPSCs) model. We edited iPSCs derived from a healthy individual to carry the APTX homozygous mutation p.H201P (H201P-iPSCs) or p.H201R (H201R-iPSCs) via CRISPR/Cas9. We found that aprataxin expression was absent in both H201P- and H201R-iPSCs. The capacity of these APTX-mutant iPSCs to differentiate into neural progenitor cells (NPCs) and mature neurons was diminished. We observed an increase in DNA single-strand breaks (SSB) via a comet assay and poly(ADP-ribose) staining, and an increase in the ratio of cleaved PARP-1/total PARP-1 in APTX-mutant NPCs and early immature neurons (EiNs), in addition of a heightened sensitivity to tert-butyl hydroperoxide in APTX-mutant EiNs. Moreover, a decrease of APE1 expression was observed in APTX-mutant NPCs and H201R-EiNs during neural differentiation. Our study established a practical iPSCs model to investigate AOA1 disease. We found that mutant aprataxin leads to defective neural differentiation, accompanied by the accumulation of DNA SSBs with increased cleaved PARP-1 and reduced APE1 expression of the base excision repair pathway.

Purchased from AmBeed:

Alternative Products

Product Details of PDD 00017273

CAS No. :1945950-21-9
Formula : C23H26N6O4S2
M.W : 514.62
SMILES Code : O=S(C1=CC2=C(N(CC3=CC(C)=NN3C)C(N(CC4=CN=C(C)S4)C2=O)=O)C=C1)(NC5(C)CC5)=O
MDL No. :MFCD30536372

Safety of PDD 00017273

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 3 μM 6 h PDD promotes MZ1-induced degradation of BRD4 Nat Commun. 2024 Jul 2;15(1):5379.
HCT116 cells 3 μM 6 h PDD promotes MZ1-induced degradation of BRD4 Nat Commun. 2024 Jul 2;15(1):5379.
UMSCC6 cells 1 µM 16 h PDD00017273 significantly reduced the survival of UMSCC6 cells following high-LET proton irradiation, indicating that PARG plays a crucial role in the repair of complex DNA damage induced by high-LET protons. Cell Death Dis. 2024 Feb 17;15(2):150.
FaDu cells 1 µM 16 h PDD00017273 significantly reduced the survival of FaDu cells following high-LET proton irradiation, indicating that PARG plays a crucial role in the repair of complex DNA damage induced by high-LET protons. Cell Death Dis. 2024 Feb 17;15(2):150.
HeLa cells 1 µM 16 h PDD00017273 significantly reduced the survival of HeLa cells following high-LET proton irradiation, indicating that PARG plays a crucial role in the repair of complex DNA damage induced by high-LET protons. Cell Death Dis. 2024 Feb 17;15(2):150.
pancreatic cancer cells 1 µM 24 h To evaluate the effect of PDD00017273 on ZZW-115-induced cell death, it was found that PDD00017273 enhanced the cell death effect Commun Biol. 2022 Jul 22;5(1):732.
MC3T3-E1 cells 1 µM 28 days PDD00017273 significantly enhanced ALP activity and promoted mineralization at day 28. Int J Mol Sci. 2022 May 2;23(9):5041.
MC3T3-E1 cells 1 µM 24 h PDD00017273 significantly increased intracellular PAR levels, indicating inhibition of PARG enzymatic activity. Int J Mol Sci. 2022 May 2;23(9):5041.
MDA-MB-231 0.3 μM 16 h PDD00017273 also showed sensitization to ionizing radiation in MDA-MB-231 cells. DNA Repair (Amst). 2018 Jan;61:25-36.
MCF-7 0.3 μM 16 h PDD00017273 was used to inhibit PARG activity, leading to the accumulation and persistence of PAR, thereby increasing sensitivity to ionizing radiation. DNA Repair (Amst). 2018 Jan;61:25-36.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.94mL

0.39mL

0.19mL

9.72mL

1.94mL

0.97mL

19.43mL

3.89mL

1.94mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories